India to France: Valsartan Export Trade Route

The India to France Valsartan corridor is one of India's established pharmaceutical export routes, with 208 shipments documented worth a combined $4.0M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's valsartan manufacturing sector.

Across 14 active suppliers, the average shipment value stands at $19.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 16.6%, placing it at rank #1 among India's top valsartan export destinations globally.

On the import side, key buyers of Indian valsartan in France include M/S. CSP MYLAN SAS AT CSP LABO 274 , CSP VIATRIS SANTE AT CSP LAB, CSP MYLAN SAS AT CSP LABO 274 and 30 others. M/S. CSP MYLAN SAS AT CSP LABO 274 is the single largest importer with 12 shipments valued at $732.3K USD.

India's valsartan exports to France are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 52 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, MYLAN LABORATORIES LIMITED , MACLEODS PHARMACEUTICALS LTD — together account for 83% of total trade value on this route. The average shipment value of $19.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as amlodipine/valsartan mylan 10 mg/160 mg and amlodipine / valsartan mylan 10 mg / 160 , suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, M/S. CSP MYLAN SAS AT CSP LABO 274 is the largest importer with 12 shipments worth $732.3K USD — representing 18% of all valsartan imports from India on this route. A total of 33 buyers are active on this corridor.